Finance

Stocks under Consideration: Neuralstem, Inc. (NASDAQ:CUR) & Quantum Corporation (NYSE:QTM)

Neuralstem, Inc. (NASDAQ:CUR)

NEURALSTEM’s patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.

Neuralstem, Inc. (NASDAQ:CUR)’s Financial Overview

Neuralstem, Inc. (NASDAQ) surged 1.42% yesterday to close its trading session at $0.39. The company has 1 year Price Target of $26. Neuralstem, Inc. has 52-Week high of $2.05 and 52-Week Low of $0.25. The stock touched its 52-Week High on 2.05 and 52-Week Low on 0.25. The stock traded with the volume of 65267 shares yesterday. The firm shows the market capitalization of $6.61 Million.

Neuralstem, Inc. (NASDAQ) reported its last quarterly earnings on 6/29/2017 where the firm reported its Actual EPS of $-0.36/share against the analyst consensus estimate of $-0.73/share. The difference between the actual and expected EPS is $0.37 a share with a surprise factor of 50.7%.

The firm is trading with SMA20 of 9.23 Percent, SMA50 of -7.3 Percent and SMA200 of -62.83 percent. Neuralstem, Inc. has P/S value of 13.22 while its P/B value stands at 1.34. Similarly, the company has Return on Assets of -74.7 percent, Return on Equity of -123.1 percent and Return on Investment of -156.6 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 1 analysts offering 12-month price forecasts for Neuralstem Inc have a median target of 26.00, with a high estimate of 26.00 and a low estimate of 26.00. The median estimate represents a +6,602.76% increase from the last price of 0.39.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Quantum Corporation (NYSE:QTM)

Quantum Corporation (NYSE:QTM)’s Financial Outlook

The 1 analysts offering 12-month price forecasts for Quantum Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +79.37% increase from the last price of 2.23.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Quantum Corporation (NYSE) in the last quarter reported its actual EPS of $-0.14/share where the analyst estimated EPS was $0.03/share. The difference between the actual and Estimated EPS is $-0.17. This shows a surprise factor of -566.7 percent.